NB
NBTX
Methodology breakdown computing — it will appear here on its own.
Nanobiotix - ADR (NBTX) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-06-01). See the full ratio breakdown and business-activity screen below for the reasoning. ⚠️ This provider verdict is about 3 months old (2026-06-01) — older than one reporting quarter, so it may predate the financial data shown below.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for NBTX — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 43.30 | NEUTRAL |
| Stochastic %K (14) | 14.72 | BUY |
| CCI (20) | -124.34 | BUY |
| Williams %R (14) | -85.28 | BUY |
| MACD (12,26,9) | -0.65 | SELL |
| ROC (10) | -17.84 | SELL |
| Momentum (10) | -8.06 | SELL |
| EMA (10) | 38.88 | SELL |
| SMA (10) | 39.12 | SELL |
| EMA (20) | 39.64 | SELL |
| SMA (20) | 40.80 | SELL |
| EMA (30) | 39.72 | SELL |
| SMA (30) | 40.03 | SELL |
| EMA (50) | 39.43 | SELL |
| SMA (50) | 39.68 | SELL |
| EMA (100) | 37.72 | SELL |
| SMA (100) | 39.14 | SELL |
| EMA (200) | 32.32 | BUY |
| SMA (200) | 32.53 | BUY |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
About Nanobiotix - ADR
Healthcare · Biotechnology
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Background via Yahoo Finance — informational, not part of the verdict.
Latest Signal — 2026-08-27
🟡 BULLISH LEAN
The main driver: RSI in healthy zone, Wall Street broadly bullish. More signals pointing up than down. Not full confluence yet, but the weight of evidence is bullish. Use `!alert NBTX [level]` to catch the entry, or `!plan NBTX` to size small.
Scores: 3 bullish / 1 bearish
Average — needs more confirmation before sizing up
SMC — Top Down
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 62 |
| ⏰ 4H | BEARISH | 28 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | RANGING | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Momentum & Volume
Peer Movement
Peer movement computing — it will appear here on its own.
Insider Activity (90d)
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.